- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/768 - Oncolytic viruses not provided for in groups
Patent holdings for IPC class A61K 35/768
Total number of patents in this class: 773
10-year publication summary
25
|
46
|
45
|
56
|
101
|
103
|
106
|
117
|
66
|
29
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Deutsches Krebsforschungszentrum | 417 |
33 |
Arizona Board of Regents on behalf of Arizona State University | 2226 |
18 |
Ruprecht-Karls-Universität Heidelberg | 265 |
18 |
Guangzhou Virotech Pharmaceutical Co., Ltd. | 24 |
17 |
Memorial Sloan-Kettering Cancer Center | 1789 |
17 |
Transgene S.A. | 128 |
15 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
14 |
Kalivir Immunotherapeutics, Inc. | 44 |
14 |
Mayo Foundation for Medical Education and Research | 2981 |
13 |
Hangzhou Converd Co., Ltd. | 34 |
13 |
Sillajen, Inc. | 31 |
13 |
Bionoxx Inc. | 19 |
13 |
National University Corporation Tottori University | 193 |
12 |
Duke University | 2872 |
11 |
Ottawa Hospital Research Institute | 102 |
11 |
Ruprecht-karls-universitaet Heidelberg | 28 |
11 |
Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts | 316 |
10 |
SillaJen Biotherapeutics, Inc. | 25 |
10 |
Turnstone Limited Partnership | 27 |
10 |
Turnstone Biologics Corp. | 12 |
10 |
Other owners | 490 |